The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 06, 2010
Filed:
Nov. 24, 2004
Christopher S. Brook, King of Prussia, PA (US);
Pingyun Y. Chen, Indianapolis, IN (US);
Wei Chen, Woodbury, MN (US);
Qunying Dai, King of Prussia, PA (US);
Philip C. Dell'orco, King of Prussia, PA (US);
Clifford S. Labaw, King of Prussia, PA (US);
Ann Marie Diederich, King of Prussia, PA (US);
Choon K. OH, Collegeville, PA (US);
Claire Hisler, Meyzieu, FR;
David H. Igo, Research Triangle Park, NC (US);
Lee M. Katrincic, King of Prussia, PA (US);
Li-jen Ping, King of Prussia, PA (US);
Paul G. Spoors, King of Prussia, PA (US);
Jun Wang, King of Prussia, PA (US);
Christopher Werner, King of Prussia, PA (US);
Christopher S. Brook, King of Prussia, PA (US);
Pingyun Y. Chen, Indianapolis, IN (US);
Wei Chen, Woodbury, MN (US);
Qunying Dai, King of Prussia, PA (US);
Philip C. Dell'Orco, King of Prussia, PA (US);
Clifford S. Labaw, King of Prussia, PA (US);
Ann Marie Diederich, King of Prussia, PA (US);
Choon K. Oh, Collegeville, PA (US);
Claire Hisler, Meyzieu, FR;
David H. Igo, Research Triangle Park, NC (US);
Lee M. Katrincic, King of Prussia, PA (US);
Li-Jen Ping, King of Prussia, PA (US);
Paul G. Spoors, King of Prussia, PA (US);
Jun Wang, King of Prussia, PA (US);
Christopher Werner, King of Prussia, PA (US);
SB Pharmco Puerto Rico Inc., Hato Rey, PR (US);
Abstract
The present invention relates to a salt of carvedilol and/or corresponding solvates thereof, compositions containing such carvedilol and/or corresponding solvates thereof, and/or methods of using the aforementioned compound(s) in the treatment of certain disease states in mammals, in particular man. The present invention further relates to carvedilol phosphate salts, and/or solvates thereof, which include a novel crystalline form of carvedilol dihydrogen phosphate (i.e., which is the dihydrogen phosphate salt of 1-(carbazol-4-yloxy-3-[[2-(o-methoxyphenoxy)ethyl]amino]-2-propanol) and/or carvedilol hydrogen phosphate, etc.) and/or other corresponding solvates thereof, compositions containing these carvedilol phosphate salts and/or solvates, and methods of using the aforementioned salts and/or solvates to treat hypertension, congestive heart failure and angina, etc.